Showing posts with label Macular edema. Show all posts
Showing posts with label Macular edema. Show all posts

Wednesday, October 07, 2009

Angiogenesis Inhibitor Works in Macular Edema



According to two studies presented at a retina meeting, patients with macular edema related to retinal vein occlusion had significant improvement in vision when treated with ranibizumab (Lucentis) in each of two dosages. In trials including approximately 400 patients apiece, researchers from Johns Hopkins University and Houston's Methodist Hospital randomized patients to monthly 0.5 mg or 0.3 mg intravitreal injections of ranibizumab, or to sham injections, for six months. Notably, 46 to 47 percent of patients in both ranibizumab groups improved by at least 15 letters, compared with 16.9 percent of the control group.
Reblog this post [with Zemanta]

Monday, September 28, 2009

Intravitreal injection of triamcinolone may improve vision in retinal vein occlusion

Interior of posterior half of bulb of left eye...Image via Wikipedia

Medscape reported that, according to a study published in the Sept. issue of the Archives of Ophthalmology, intravitreal injection of the corticosteroid triamcinolone may improve vision in retinal vein occlusion.

Researchers from the Standard Care vs. Corticosteroid for Retinal Vein Occlusion (SCORE) Study Research Group compared "the efficacy and safety of one-mg and four-mg doses of preservative-free intravitreal triamcinolone vs. observation for eyes with vision loss associated with macular edema secondary to perfused" central retinal vein occlusion "in 271 participants." They found that the the one-mg group had five-fold greater odds of achieving the primary outcome, as "did the four-mg group," with both the "one-mg and four-mg groups" being "not significantly different from each other."

Reblog this post [with Zemanta]

Twitter Delicious Facebook Digg Stumbleupon Favorites More

 
Design by Free WordPress Themes | Bloggerized by Lasantha - Premium Blogger Themes | Bluehost Review